Medical Cannabis - Western Africa

  • Western Africa
  • In Western Africa, revenue in the Medical Cannabis market market is forecasted to reach US$57.53m in 2024.
  • The revenue is anticipated to demonstrate an annual growth rate (CAGR 2024-2029) of 2.64%, leading to a market volume of US$65.55m by 2029.
  • When compared globally, the United States is expected to generate the highest revenue (US$14,530.00m in 2024).
  • In terms of total population figures, per person revenues of US$15.59k are generated in 2024.
  • Medical Cannabis investments in Western Africa are gaining traction, with Nigeria exploring regulatory frameworks to capitalize on the growing market potential.

Key regions: Australia, Europe, South Africa, United States, Netherlands

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Medical Cannabis market in Western Africa is experiencing a notable growth trajectory driven by changing customer preferences, evolving trends, and unique local special circumstances.

Customer preferences:
Customers in Western Africa are increasingly turning to Medical Cannabis products due to growing awareness about the potential health benefits associated with their usage. The shift towards natural and alternative remedies is also fueling the demand for Medical Cannabis in the region. Additionally, the cultural acceptance of traditional herbal medicine in many Western African countries is contributing to the popularity of Medical Cannabis products among consumers.

Trends in the market:
One of the prominent trends in the Medical Cannabis market in Western Africa is the gradual legalization and regulation of medical marijuana in several countries. This trend is opening up new opportunities for both domestic cultivation and international trade of Medical Cannabis products. Moreover, the rising investments in research and development activities focused on Medical Cannabis are driving innovation and product diversification in the market.

Local special circumstances:
Western Africa presents unique local circumstances that are influencing the development of the Medical Cannabis market in the region. The presence of a rich history of herbal medicine traditions and practices is shaping consumer attitudes towards Medical Cannabis products. Additionally, the varying regulatory frameworks across different countries in Western Africa are impacting the accessibility and availability of Medical Cannabis within the region.

Underlying macroeconomic factors:
The growth of the Medical Cannabis market in Western Africa is also influenced by underlying macroeconomic factors such as demographic trends, healthcare infrastructure, and government policies. The increasing population and changing demographics in the region are creating a larger consumer base for Medical Cannabis products. Furthermore, improvements in healthcare infrastructure and the adoption of more progressive policies related to Medical Cannabis are facilitating market growth and expansion in Western Africa.

Methodology

Data coverage:

Data encompasses B2B and B2C enterprises. Figures are based on companies' revenues, funding values and global consumer survey data. Revenues include retail, sales and taxes.

Modeling approach / Market size:

Market sizes are determined by a Top-Down approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports, third-party data. Next, we use relevant key market indicators and data from country-specific associations such as tobacco spending per capita, medical product spending per capita, consumer spending and consumer spending for recreation purposes, population. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Users
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)